| Financial Year |
March 31 2023 |
| Monetary Funds |
1,048,591,399.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,934,026.44 |
| Accounts Receivable |
38,326,941.77 |
| Advances to Suppliers |
39,445,433.39 |
| Other Receivables |
24,097,630.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
418,533,052.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,751,339.55 |
| Total Current Assets |
1,614,421,818.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
410,091,559.03 |
| Under-construction Projects |
32,877,444.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
161,513,632.82 |
| R&D expenses |
-- |
| Goodwill |
56,379,215.14 |
| Long-Term Deferred and Prepaid Expenses |
447,421.81 |
| Deferred Income Tax Assets |
17,300,366.87 |
| Other Non-Current Assets |
37,536,408.93 |
| Sub-Total of Non-Current Assets |
724,418,042.40 |
| Total Assets |
2,338,839,861.22 |
| Short-Term Loans |
47,480,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,190,407.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,562,169.28 |
| Taxes Payable |
24,577,992.75 |
| Interest Payable |
-- |
| Dividend Payable |
3,378,800.00 |
| Other payables |
43,953,901.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
5,678,174.07 |
| Sub-Total of Current Liabilities |
277,562,205.80 |
| Long-term Loans |
-- |
| Bonds Payable |
293,558,311.38 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
800,000.00 |
| Deferred Income Tax Liabilities |
15,965,455.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
331,575,849.75 |
| Total Liabilities |
609,138,055.55 |
| Paid-In Capital(Or Share Stock) |
435,462,583.00 |
| Capital Surplus |
84,782,726.78 |
| Surplus Reserve |
135,480,215.53 |
| LESS:Treasury Stock |
20,396,504.06 |
| Undistributed Profits |
856,153,936.04 |
| Minority Stockholder's Interest |
170,543,386.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,559,158,418.88 |
| Owner's Equity（Stockholder's Equity） |
1,729,701,805.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,338,839,861.22 |
